Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 79
Filter
1.
Eur J Dermatol ; 33(1): 6-11, 2023 Feb 01.
Article in English | MEDLINE | ID: mdl-37154809

ABSTRACT

BACKGROUND: Rosacea prevalence varies worldwide and there is a lack of information in Brazil. OBJECTIVES: To describe the epidemiological profile of rosacea in subjects who consulted in dermatological outpatient clinics in Brazil. MATERIALS & METHODS: A cross-sectional study was conducted in 13 dermatological outpatient clinics across the country. Patients with rosacea diagnosis were eligible for the study according to the investigator's clinical assessment. Clinical, social and demographic data were collected. The overall and regional rosacea prevalence was calculated, and association with baseline characteristics was analysed. RESULTS: A total of 3,184 subjects were enrolled, and rosacea prevalence was 12.7%. The southern region of Brazil presented a higher prevalence, followed by the southeast. The subjects in the rosacea group were older than those without rosacea (52.5 ±14.9 vs. 47.5 ±17.5; p<0.001). Moreover, the rosacea group was associated with Fitzpatrick's phototypes I and II, Caucasian ethnicity, a family history of rosacea, and facial erythema, however, no association with gender was found. The most prevalent clinical sign and clinical subtype in rosacea patients were erythema and erythematotelangiectatic, respectively. CONCLUSION: Rosacea is highly prevalent in Brazil, mostly in the southern region, associated with phototypes I and II and a family history.


Subject(s)
Dermatology , Rosacea , Humans , Brazil/epidemiology , Cross-Sectional Studies , Rosacea/epidemiology , Rosacea/complications , Erythema/complications
2.
Front Immunol ; 12: 586320, 2021.
Article in English | MEDLINE | ID: mdl-33936027

ABSTRACT

Since the first description of the syndrome of sideroblastic anemia with immunodeficiency, fevers and development delay (SIFD), clinical pictures lacking both neurological and hematological manifestations have been reported. Moreover, prominent skin involvement, such as with relapsing erythema nodosum, is not a common finding. Up to this moment, no genotype and phenotype correlation could be done, but mild phenotypes seem to be located in the N or C part. B-cell deficiency is a hallmark of SIFD syndrome, and multiple others immunological defects have been reported, but not high levels of double negative T cells. Here we report a Brazilian patient with a novel phenotype of SFID syndrome, carrying multiple immune defects and harboring a novel mutation on TRNT1 gene.


Subject(s)
Anemia, Sideroblastic/diagnosis , Anemia, Sideroblastic/etiology , Developmental Disabilities/diagnosis , Disease Susceptibility , Fever , Immunologic Deficiency Syndromes/diagnosis , Phenotype , Alleles , Biopsy , DNA Mutational Analysis , Female , Genetic Association Studies , Genetic Predisposition to Disease , Genotype , Humans , Lymphocytes/immunology , Lymphocytes/metabolism , Mutation
4.
Dermatol Ther ; 34(1): e14622, 2021 01.
Article in English | MEDLINE | ID: mdl-33269529

ABSTRACT

Female androgenetic alopecia is one cause of alopecia in women, although the ideal treatment for this condition remains far from defined. The objective of this study was to evaluate the efficacy and safety of intradermal injections with 0.5% minoxidil for the management of female androgenetic alopecia in a randomized, placebo-controlled trial. A total of 54 women diagnosed with female androgenetic alopecia were divided into two groups: one group received intradermal injections of 0.5% minoxidil, and the other received 0.9% saline. Biopsy, trichogram, Trichoscan (Tricholog GmbH, Freiburg, Germany), and self-assessment findings were used to evaluate the outcomes of treatment with minoxidil. In the treated group, there was a significant increase in the terminal-to-vellus hair ratio (P < .001) and in the percentage of anagen hairs (P = .048) and an improvement in hair loss and volume (P = .021 and P = .028, respectively). These results show that intradermal injections with minoxidil were more effective than placebo (P < .001) in the treatment of female androgenetic alopecia with a good safety profile.


Subject(s)
Alopecia , Minoxidil , Administration, Topical , Alopecia/diagnosis , Alopecia/drug therapy , Double-Blind Method , Female , Hair , Humans , Injections, Intradermal , Minoxidil/adverse effects , Treatment Outcome
5.
An. bras. dermatol ; 95(2): 207-209, Mar.-Apr. 2020. graf
Article in English | LILACS, Coleciona SUS | ID: biblio-1130852

ABSTRACT

Abstract Infantile hemangioma is the most common pediatric vascular tumor, with the following risk factors: low birth weight, prematurity, white skin, female gender, multiparity and advanced maternal age. The use of oral and topical beta-blockers, although recent, has emerged as the first line of treatment, with superior safety and efficacy to previously used therapies, such as corticosteroids and surgeries. This report describes two cases of nasal tip infantile hemangioma, treated with oral propranolol. Both presented excellent therapeutic responses.


Subject(s)
Humans , Female , Infant , Propranolol/administration & dosage , Nose Neoplasms/drug therapy , Adrenergic beta-Antagonists/administration & dosage , Hemangioma/drug therapy , Nose Neoplasms/pathology , Administration, Oral , Treatment Outcome , Hemangioma/pathology
6.
J Cosmet Dermatol ; 19(10): 2634-2636, 2020 Oct.
Article in English | MEDLINE | ID: mdl-32009297

ABSTRACT

Baker-Gordon formula phenol chemical peel remains the most effective and long-lasting treatment for deep facial lines. However, this treatment is associated with risk of serious complications, such as arrhythmias and dystrophic scars. With the emergence of new and safer technologies for facial rejuvenation, such as fractionated carbon dioxide (CO2) lasers and microneedling, there has been a decrease in the use of deep chemical peels. This raises the question of whether there is still a place for deep phenol chemical peels. In this sense, we present a successful case of using Baker-Gordon formula phenol chemical peel at the perioral region for treating advanced wrinkles. This technique is called "Regional Phenol Peeling" and is safer than the use of the formula applied to the entire face, since it does not need systemic monitoring.


Subject(s)
Chemexfoliation , Skin Aging , Dermabrasion , Humans , Phenol , Rejuvenation
7.
An Bras Dermatol ; 95(2): 207-209, 2020.
Article in English | MEDLINE | ID: mdl-32061465

ABSTRACT

Infantile hemangioma is the most common pediatric vascular tumor, with the following risk factors: low birth weight, prematurity, white skin, female gender, multiparity and advanced maternal age. The use of oral and topical beta-blockers, although recent, has emerged as the first line of treatment, with superior safety and efficacy to previously used therapies, such as corticosteroids and surgeries. This report describes two cases of nasal tip infantile hemangioma, treated with oral propranolol. Both presented excellent therapeutic responses.


Subject(s)
Adrenergic beta-Antagonists/administration & dosage , Hemangioma/drug therapy , Nose Neoplasms/drug therapy , Propranolol/administration & dosage , Administration, Oral , Female , Hemangioma/pathology , Humans , Infant , Nose Neoplasms/pathology , Treatment Outcome
8.
J Cosmet Dermatol ; 18(6): 1629-1631, 2019 Dec.
Article in English | MEDLINE | ID: mdl-30838729

ABSTRACT

We present a case report of a hyaluronic acid filler-induced complication documented using high-frequency ultrasound. We regard the scientific value of the case as indicating the benefit that ultrasound provides for the management and documentation of this complication. This technology has been becoming increasingly widespread in the care of patients who experience unwanted effects of hyaluronic acid filler because it can be used for the high-resolution visualization of skin layers as well as the differentiation of filler types and their relationships with adjacent tissues (via gray scale or B-mode ultrasound) and blood vessels (via color Doppler ultrasound). In addition, it was possible to conclude that external vascular compression causes clinical repercussions, a fact that is often questioned by some dermatologists. This questioning is based on the vast vascularization and anastomosis of arteries of the face, which should permit compensation for vascular compression. However, in this case, there was no doubt that compression caused a region of low output with the clinical manifestation of peri-oral pallor. Ultrasound was used to document the compression of a vessel by the filler; after application of hyaluronidase, increased vessel lumen and clinical reversal of hypoperfusion in the affected area were observed.


Subject(s)
Arterial Occlusive Diseases/diagnosis , Cosmetic Techniques/adverse effects , Dermal Fillers/adverse effects , Hyaluronic Acid/adverse effects , Ultrasonography, Doppler, Color , Adult , Arterial Occlusive Diseases/drug therapy , Arterial Occlusive Diseases/etiology , Arteries/diagnostic imaging , Cheek/diagnostic imaging , Dermal Fillers/administration & dosage , Female , Humans , Hyaluronic Acid/administration & dosage , Hyaluronoglucosaminidase/therapeutic use , Injections, Subcutaneous/adverse effects , Rejuvenation , Skin/blood supply , Treatment Outcome , Vascular Patency
9.
J Cosmet Dermatol ; 18(3): 908-909, 2019 Jun.
Article in English | MEDLINE | ID: mdl-30160077

ABSTRACT

Intralesional corticoid infiltration guided by 22-MHz ultrasound is a new, noninvasive, and safe dermatological method for the treatment of foreign body granuloma. The great advantage of the procedure is that the medication is delivered straight to the desired target, preventing adverse treatment effects in noninjured areas.


Subject(s)
Glucocorticoids/administration & dosage , Granuloma, Foreign-Body/therapy , Triamcinolone/administration & dosage , Aged , Biopsy , Cosmetic Techniques/adverse effects , Dermal Fillers/administration & dosage , Dermal Fillers/adverse effects , Female , Granuloma, Foreign-Body/diagnostic imaging , Granuloma, Foreign-Body/etiology , Humans , Injections, Intralesional , Polymethyl Methacrylate/administration & dosage , Polymethyl Methacrylate/adverse effects , Skin/diagnostic imaging , Skin/drug effects , Skin/pathology , Treatment Outcome , Ultrasonography, Interventional
10.
Rev Soc Bras Med Trop ; 50(4): 562-564, 2017.
Article in English | MEDLINE | ID: mdl-28954083

ABSTRACT

Wade's histoid leprosy (HL) is a rare variant of multibacillary leprosy, with characteristic clinical, immunologic, histopathologic, and bacteriologic features. It is associated with resistance to sulfa drugs or polychemotherapy and is rarely observed in patients who have not undergone prior treatment. Clinically, HL resembles keloid or dermatofibroma. Furthermore, HL is rare in children and is difficult to diagnose even by experts. This report describes a case of HL in a 14-year-old Brazilian boy, who presented with multiple nodular and tumor-like lesions, simulating keloids. He had not undergone prior treatment with anti-leprosy drugs, which accentuates the relevance of this case report.


Subject(s)
Leprosy, Multibacillary/diagnosis , Adolescent , Diagnosis, Differential , Humans , Leprosy, Multibacillary/pathology , Male , Skin/pathology
11.
Rev. Soc. Bras. Med. Trop ; 50(4): 562-564, July-Aug. 2017. graf
Article in English | LILACS | ID: biblio-896989

ABSTRACT

Abstract Wade's histoid leprosy (HL) is a rare variant of multibacillary leprosy, with characteristic clinical, immunologic, histopathologic, and bacteriologic features. It is associated with resistance to sulfa drugs or polychemotherapy and is rarely observed in patients who have not undergone prior treatment. Clinically, HL resembles keloid or dermatofibroma. Furthermore, HL is rare in children and is difficult to diagnose even by experts. This report describes a case of HL in a 14-year-old Brazilian boy, who presented with multiple nodular and tumor-like lesions, simulating keloids. He had not undergone prior treatment with anti-leprosy drugs, which accentuates the relevance of this case report.


Subject(s)
Humans , Leprosy, Multibacillary/pathology , Skin/pathology , Diagnosis, Differential , Leprosy, Multibacillary/diagnosis
12.
J Cosmet Dermatol ; 16(3): 319-326, 2017 Sep.
Article in English | MEDLINE | ID: mdl-28349655

ABSTRACT

Chemical peeling, a procedure wherein a chemical agent is applied to the skin to cause controlled destruction followed by regeneration and remodeling, is a dynamic tool for the treatment of acne, pigmentation issues, and photoaging [Journal of cutaneous and aesthetic surgery vol. 5 (2012) 254-260]. The results and complications are related to the depth of the procedure, with deeper peels producing more marked results and higher rates of complications. Complications are more likely with darker skin types, certain peeling agents, and sun exposure after treatment [Journal of cutaneous and aesthetic surgery vol. 5 (2012) 254-260]. They can range from minor irritations and uneven pigmentation to permanent scarring. In extremely uncommon cases, the complications can be life-threatening. This knowledge is essential to prevent, reduce, and eliminate the occurrence of complications [Cirurgia dermatológica em consultório. São Paulo: Atheneu; 2009]. Swelling, pain, persistent erythema, pruritus, allergic reactions, folliculitis/acne, infection, herpes recurrence, hypopigmentation and hyperpigmentation, demarcation lines, and scarring are some of the complications that will be discussed in this article. The first step in preventing complications is to identify the patients at risk. By doing so, complications can be anticipated, prevented, and, if they still occur, treated as early as possible.


Subject(s)
Chemexfoliation/adverse effects , Acne Vulgaris/etiology , Blister/etiology , Cicatrix/etiology , Cysts/etiology , Dermatitis, Allergic Contact/etiology , Ecchymosis/etiology , Edema/etiology , Erythema/etiology , Eye Injuries/etiology , Folliculitis/etiology , Humans , Infections/etiology , Pain/etiology , Pigmentation Disorders/etiology , Pruritus/etiology , Telangiectasis/etiology
13.
Rev Soc Bras Med Trop ; 49(5): 660-662, 2016.
Article in English | MEDLINE | ID: mdl-27812668

ABSTRACT

The human T-cell lymphotropic virus-1 (HTLV-1) affects worldwide population; the estimated number of currently infected individuals is 10-20 million. In this report, we describe the clinical findings of three family members with vertical transmission of HTLV-1. This case report highlights the importance of healthcare providers who have optimal knowledge about HTLV-1 including its transmission and pertinent attributes, and who are able to provide affected individuals with adequate information regarding their condition.


Subject(s)
HTLV-I Infections/transmission , Infectious Disease Transmission, Vertical , Child , Female , Humans
14.
Rev. Soc. Bras. Med. Trop ; 49(5): 660-662, Sept.-Oct. 2016. graf
Article in English | LILACS | ID: lil-798114

ABSTRACT

Abstract The human T-cell lymphotropic virus-1 (HTLV-1) affects worldwide population; the estimated number of currently infected individuals is 10-20 million. In this report, we describe the clinical findings of three family members with vertical transmission of HTLV-1. This case report highlights the importance of healthcare providers who have optimal knowledge about HTLV-1 including its transmission and pertinent attributes, and who are able to provide affected individuals with adequate information regarding their condition.


Subject(s)
Humans , Female , Child , HTLV-I Infections/transmission , Infectious Disease Transmission, Vertical
15.
An Bras Dermatol ; 91(1): 34-9, 2016.
Article in English | MEDLINE | ID: mdl-26982776

ABSTRACT

BACKGROUND: The role played by vitamin D in atopic dermatitis is controversial and has been the focus of many studies. The ultraviolet index has not been considered in this type of research. OBJECTIVES: The objectives of the study were to assess 25-hydroxy vitamin D [25(OH)D] serum level in atopic dermatitis patients and control group, to investigate the association between atopic dermatitis clinical severity (using the SCORing Atopic Dermatitis index - SCORAD) and 25(OH)D serum levels, and to evaluate the independent predictors, including Ultraviolet index, SCORAD and 25(OH)D. METHODS: We conducted a cross-sectional study of 106 atopic dermatitis patients. A control group was matched with a subsample of 54 participants with atopic dermatitis. SCORAD index, laboratory tests, and local Ultraviolet index were assessed. RESULTS: The atopic dermatitis patients had serum 25(OH)D levels and mean UVI significantly higher than the control group. Immunoglobulin E and Ultraviolet index were associated with the SCORAD index. Skin type, age and Ultraviolet index were independent predictors of 25(OH)D. CONCLUSIONS: Although statistically significant, the different levels of 25(OH)D between the paired groups may be attributed to the higher mean Ultraviolet index in atopic dermatitis patients. Since Ultraviolet index is an independent predictor of SCORAD index and of 25(OH)D level, it may work as a confounding factor in studies involving atopic dermatitis and 25(OH)D and must be considered in this kind of research.


Subject(s)
Dermatitis, Atopic/blood , Ultraviolet Rays , Vitamin D Deficiency/epidemiology , Vitamin D/analogs & derivatives , Adolescent , Brazil/epidemiology , Case-Control Studies , Child , Child, Preschool , Cross-Sectional Studies , Dermatitis, Atopic/etiology , Dermatitis, Atopic/pathology , Female , Humans , Immunoglobulin E/blood , Male , Reference Values , Risk Factors , Seasons , Severity of Illness Index , Statistics, Nonparametric , Sunlight/adverse effects , Time Factors , Ultraviolet Rays/adverse effects , Vitamin D/blood , Vitamin D Deficiency/complications
16.
An. bras. dermatol ; 91(1): 34-39, Jan.-Feb. 2016. tab, graf
Article in English | LILACS | ID: lil-776418

ABSTRACT

Abstract BACKGROUND: The role played by vitamin D in atopic dermatitis is controversial and has been the focus of many studies. The ultraviolet index has not been considered in this type of research. OBJECTIVES: The objectives of the study were to assess 25-hydroxy vitamin D [25(OH)D] serum level in atopic dermatitis patients and control group, to investigate the association between atopic dermatitis clinical severity (using the SCORing Atopic Dermatitis index - SCORAD) and 25(OH)D serum levels, and to evaluate the independent predictors, including Ultraviolet index, SCORAD and 25(OH)D. METHODS: We conducted a cross-sectional study of 106 atopic dermatitis patients. A control group was matched with a subsample of 54 participants with atopic dermatitis. SCORAD index, laboratory tests, and local Ultraviolet index were assessed. RESULTS: The atopic dermatitis patients had serum 25(OH)D levels and mean UVI significantly higher than the control group. Immunoglobulin E and Ultraviolet index were associated with the SCORAD index. Skin type, age and Ultraviolet index were independent predictors of 25(OH)D. CONCLUSIONS: Although statistically significant, the different levels of 25(OH)D between the paired groups may be attributed to the higher mean Ultraviolet index in atopic dermatitis patients. Since Ultraviolet index is an independent predictor of SCORAD index and of 25(OH)D level, it may work as a confounding factor in studies involving atopic dermatitis and 25(OH)D and must be considered in this kind of research.


Subject(s)
Adolescent , Child , Child, Preschool , Female , Humans , Male , Dermatitis, Atopic/blood , Ultraviolet Rays , Vitamin D Deficiency/epidemiology , Vitamin D/analogs & derivatives , Brazil/epidemiology , Case-Control Studies , Cross-Sectional Studies , Dermatitis, Atopic/etiology , Dermatitis, Atopic/pathology , Immunoglobulin E/blood , Reference Values , Risk Factors , Seasons , Severity of Illness Index , Statistics, Nonparametric , Sunlight/adverse effects , Time Factors , Ultraviolet Rays/adverse effects , Vitamin D Deficiency/complications , Vitamin D/blood
18.
An. bras. dermatol ; 90(6): 779-779, Nov.-Dec. 2015.
Article in English | LILACS | ID: lil-769528
SELECTION OF CITATIONS
SEARCH DETAIL
...